Ophthalmology News

Ophthal

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Shen X et al. – Interleukin–1 beta decreases expression of glutamine synthetase via activation of c–Jun. The data suggested that interleukin–1 beta may play a role in the development of diabetic retinopathy.

Related Articles

Retinopathy - screening recommendations
Australian Family Physician, 10/06/09    Relevance Score: 92%

Identification of independent risk factors for the development of diabetic retinopathy requiring treatment
Acta Ophthalmologica, 11/18/09    Relevance Score: 89%

Glyceraldehyde 3 phosphate dehydrogenase in retinal microvasculature: Implications for the development and progression of diabetic retinopathy
Investigative Ophthalmology and Visual Science, 11/18/09    Relevance Score: 88%

Prevalence and Severity of Hypertensive Retinopathy in Children
Clinical Pediatrics, 10/22/09    Relevance Score: 88%

Diabetic Retinopathy Screening Update
Clinical Diabetes, 10/19/09    Relevance Score: 88%

Today in Basic Science/Genetics...keeping you current

A novel genetic variant of BMP2K contributes to high myopia
Journal of Clinical Laboratory Analysis, 12/07/09

NADPH oxidase expression and production of superoxide by human corneal stromal cells
Molecular Vision, 12/04/09

Phenotypic characterisation and ZEB1 mutational analysis in posterior polymorphous corneal dystrophy in a New Zealand population
Molecular Vision, 12/04/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address